Gufic Biosciences Limited Financial Overview
Gufic Biosciences Limited's market cap is currently ₹35.24B. The company's EPS TTM is ₹1.678; its P/E ratio is 61.92; and it has a dividend yield of 0.03%. Gufic Biosciences Limited is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.